IGFBP4 Antikörper (AA 66-92)

Produktnummer ABIN3031355

Produktdetails anti-IGFBP4 Antikörper

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Bindungsspezifität: AA 66-92

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser IGFBP4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Kreuzreaktivität (Details): Expected species reactivity: Bovine, Pig

Aufreinigung: Antigen affinity purified

Immunogen: A portion of amino acids 66-92 from the human protein was used as the immunogen for this IGFBP4 antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Titration of the IGFBP4 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,Flow Cytometry: 1:10-1:50

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the IGFBP4 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Details zu IGFBP4

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Andere Bezeichnung: IGFBP4 (IGFBP4 Produkte)

Synonyme: IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper

Hintergrund: IGFBP4 has an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.

UniProt: P22692

Pathways: WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process